No Data
No Data
Express News | Jefferies Initiates Coverage On Douglas Emmett With Hold Rating, Announces Price Target of $16
Douglas Emmett Analyst Ratings
U.S. Companies Scrub DEI From Annual Reports as Trump Targets 'Illegal Discrimination': FT
Notable Healthcare Headlines for the Week: Viatris, J&J, Walgreens Boots Alliance Teladoc Health and Pfizer in Focus
Douglas Emmett Inc To Go Ex-Dividend On March 31st, 2025 With 0.19 USD Dividend Per Share
Press Release: Douglas Emmett Declares Quarterly Cash Dividend